Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 3, 2014, Pages 1402-1408

  Gu, Sherry ^a   Glaug, Natalie ^b   Cnaan, Avital ^b   Packer, Roger J ^b   Avery, Robert A ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Ganglion cell; Neurofibromatosis type 1; Oct; Optic pathway glioma; Pediatric

Indexed keywords

ABNORMAL VISION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MACULAR THICKNESS; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; PERIMETRY; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; SCHOOL CHILD; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; VISUAL IMPAIRMENT;

GANGLION CELL; NEUROFIBROMATOSIS TYPE 1; OCT; OPTIC PATHWAY GLIOMA; PEDIATRIC;

CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NERVE FIBERS; OPTIC NERVE GLIOMA; RETINAL GANGLION CELLS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISION, LOW; VISUAL ACUITY; VISUAL FIELDS;

EID: 84896330845     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13119     Document Type: Article

References (40)

1. Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuroophthalmol. 2011; 31:269-278.
2. Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol. 2007; 61:189-198.
3. North KN, Riccardi V, Samango-Sprouse C, et al. Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force. Neurology. 1997; 48:1121-1127.
4. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007; 6:340- 351.
5. Avery RA, Bouffet E, Packer RJ, Reginald A. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas. Invest Ophthalmol Vis Sci. 2013; 54:1034-1038.
6. Fisher MJ, Loguidice M, Gutmann DH, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol. 2012; 14:790-797.
7. Hood DC, Kardon RH. A framework for comparing structural and functional measures of glaucomatous damage. Prog Retin Eye Res. 2007; 26:688-710.
8. Hood DC, Anderson SC, Wall M, Raza AS, Kardon RH. A test of a linear model of glaucomatous structure-function loss reveals sources of variability in retinal nerve fiber and visual field measurements. Invest Ophthalmol Vis Sci. 2009; 50:4254- 4266.
9. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006; 113:324-332.
10. Danesh-Meyer HV, Carroll SC, Foroozan R, et al. Relationship between retinal nerve fiber layer and visual field sensitivity as measured by optical coherence tomography in chiasmal compression. Invest Ophthalmol Vis Sci. 2006; 47:4827-4835.
11. Danesh-Meyer HV, Papchenko T, Savino PJ, Law A, Evans J, Gamble GD. In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis Sci. 2008; 49:1879-1885.
12. Grainger BT, Papchenko TL, Danesh-Meyer HV. Optic nerve atrophy in adrenoleukodystrophy detectable by optic coherence tomography. J Clin Neurosci. 2010; 17:122-124.
13. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991; 254:1178-1181.
14. Schuman JS, Hee MR, Puliafito CA, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 1995; 113:586-596.
15. Sehi M, Zhang X, Greenfield DS, et al. Retinal nerve fiber layer atrophy is associated with visual field loss over time in glaucoma suspect and glaucomatous eyes. Am J Ophthalmol. 2012; 155:73-82.
16. Kanamori A, Nakamura M, Yamada Y, Negi A. Longitudinal study of retinal nerve fiber layer thickness and ganglion cell complex in traumatic optic neuropathy. Arch Ophthalmol. 2012; 130:1067-1069.
17. Walter SD, Ishikawa H, Galetta KM, et al. Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology. 2012; 119:1250-1257.
18. Kardon RH. Role of the macular optical coherence tomography scan in neuro-ophthalmology. J Neuroophthalmol. 2011; 31:353-361.
19. Hood DC, Fortune B, Arthur SN, et al. Blood vessel contributions to retinal nerve fiber layer thickness profiles measured with optical coherence tomography. J Glaucoma. 2008; 17:519-528.
20. Hood DC, Salant JA, Arthur SN, Ritch R, Liebmann JM. The location of the inferior and superior temporal blood vessels and interindividual variability of the retinal nerve fiber layer thickness. J Glaucoma. 2010; 19:158-166.
21. Avery RA, Liu GT, Fisher MJ, et al. Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol. 2011; 151:542-549.
22. Chang L, El-Dairi MA, Frempong TA, et al. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. J AAPOS. 2010; 14:511- 517.
23. Lambert SR, Buckley EG, Drews-Botsch C, et al. The infant aphakia treatment study: design and clinical measures at enrollment. Arch Ophthalmol. 2010; 128:21-27.
24. Maldonado RS, Izatt JA, Sarin N, et al. Optimizing hand-held spectral domain optical coherence tomography imaging for neonates, infants, and children. Invest Ophthalmol Vis Sci. 2010; 51:2678-2685.
25. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986; 42:121-130.
26. Cunha LP, Costa-Cunha LV, Malta RF, Monteiro ML. Comparison between retinal nerve fiber layer and macular thickness measured with OCT detecting progressive axonal loss following traumatic optic neuropathy. Arq Bras Oftalmol. 2009; 72:622-625.
27. Medeiros F. Axonal loss after traumatic optic neuropathy documented by optical coherence tomography. Am J Ophthalmol. 2003; 135:406-408.
28. Raza AS, Cho J, de Moraes CG, et al. Retinal ganglion cell layer thickness and local visual field sensitivity in glaucoma. Arch Ophthalmol. 2011; 129:1529-1536.
29. Curcio CA, Allen KA. Topography of ganglion cells in human retina. J Comp Neurol. 1990; 300:5-25.
30. Avery RA, Hwang EI, Ishikawa H, et al. Hand-held optical coherence tomography during sedation in young children with optic pathway gliomas. JAMA Ophthalmol. In press.
31. Seigo MA, Sotirchos ES, Newsome S, et al. In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol. 2012; 259:2119-2130.
32. Sotirchos ES, Seigo MA, Calabresi PA, Saidha S. Comparison of point estimates and average thicknesses of retinal layers measured using manual optical coherence tomography segmentation for quantification of retinal neurodegeneration in multiple sclerosis. Curr Eye Res. 2013; 38:224-228.
33. Davies EC, Galetta KM, Sackel DJ, et al. Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique. J Neuroophthalmol. 2011; 31:260-264.
34. Cabrera MT, Maldonado RS, Toth CA, et al. Subfoveal fluid in healthy full-term newborns observed by handheld spectraldomain optical coherence tomography. Am J Ophthalmol. 2012; 153:167-175.
35. Chavala SH, Farsiu S, Maldonado R, Wallace DK, Freedman SF, Toth CA. Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging. Ophthalmology. 2009; 116:2448-2456.
36. Maldonado RS, O'Connell RV, Sarin N, et al. Dynamics of human foveal development after premature birth. Ophthalmology. 2011; 118:2315-2325.
37. Scott AW, Farsiu S, Enyedi LB, Wallace DK, Toth CA. Imaging the infant retina with a hand-held spectral-domain optical coherence tomography device. Am J Ophthalmol. 2009; 147: 364-373.
38. Vajzovic L, Hendrickson AE, O'Connell RV, et al. Maturation of the human fovea: correlation of spectral-domain optical coherence tomography findings with histology. Am J Ophthalmol. 2012; 154:779-789.
39. Muni RH, Kohly RP, Charonis AC, Lee TC. Retinoschisis detected with handheld spectral-domain optical coherence tomography in neonates with advanced retinopathy of prematurity. Arch Ophthalmol. 2010; 128:57-62.
40. Muni RH, Kohly RP, Sohn EH, Lee TC. Hand-held spectral domain optical coherence tomography finding in shaken-baby syndrome. Retina. 2010; 30:S45-50.